Cargando…

Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing

Detalles Bibliográficos
Autores principales: Lewis, Joseph M., Railton, Eimear, Riordan, Andrew, Khoo, Saye, Chaponda, Mas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856184/
https://www.ncbi.nlm.nih.gov/pubmed/27128333
http://dx.doi.org/10.1097/QAD.0000000000001055
_version_ 1782430463681363968
author Lewis, Joseph M.
Railton, Eimear
Riordan, Andrew
Khoo, Saye
Chaponda, Mas
author_facet Lewis, Joseph M.
Railton, Eimear
Riordan, Andrew
Khoo, Saye
Chaponda, Mas
author_sort Lewis, Joseph M.
collection PubMed
description
format Online
Article
Text
id pubmed-4856184
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-48561842016-05-23 Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing Lewis, Joseph M. Railton, Eimear Riordan, Andrew Khoo, Saye Chaponda, Mas AIDS Correspondence Lippincott Williams & Wilkins 2016-05-15 2016-05-03 /pmc/articles/PMC4856184/ /pubmed/27128333 http://dx.doi.org/10.1097/QAD.0000000000001055 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Correspondence
Lewis, Joseph M.
Railton, Eimear
Riordan, Andrew
Khoo, Saye
Chaponda, Mas
Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
title Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
title_full Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
title_fullStr Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
title_full_unstemmed Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
title_short Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
title_sort early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856184/
https://www.ncbi.nlm.nih.gov/pubmed/27128333
http://dx.doi.org/10.1097/QAD.0000000000001055
work_keys_str_mv AT lewisjosephm earlyexperienceofdolutegravirpharmacokineticsinpregnancyhighmaternallevelsandsignificantfoetalexposurewithtwicedailydosing
AT railtoneimear earlyexperienceofdolutegravirpharmacokineticsinpregnancyhighmaternallevelsandsignificantfoetalexposurewithtwicedailydosing
AT riordanandrew earlyexperienceofdolutegravirpharmacokineticsinpregnancyhighmaternallevelsandsignificantfoetalexposurewithtwicedailydosing
AT khoosaye earlyexperienceofdolutegravirpharmacokineticsinpregnancyhighmaternallevelsandsignificantfoetalexposurewithtwicedailydosing
AT chapondamas earlyexperienceofdolutegravirpharmacokineticsinpregnancyhighmaternallevelsandsignificantfoetalexposurewithtwicedailydosing